Page 4 - Jack Anders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jack anders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jack Anders Today - Breaking & Trending Today

Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript

Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript February 26, 2024 Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-1.14 EPS, expectations were $-0.86. Revolution Medicines, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day […] ....

Jack Anders , Mark Goldsmith , Warren Buffett , Jp Morgan , Triple Meeting , Chief Financial Officer , Prev Med , With Hot , Wet Equatorial Climate , Dividend Stocks , Buy According , Chief Medical Officer , Selective Inhibitor , Revolution Medicine , Jack Anders , Chief Executive Officer , Corporate Presentation , Clinical Development ,

Revolution Medicines (NASDAQ:RVMD) Announces Earnings Results, Misses Estimates By $0.29 EPS

Revolution Medicines (NASDAQ:RVMD – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($1.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.85) by ($0.29), Briefing.com reports. Revolution Medicines had a negative net margin of 1,003.36% and a negative return on equity of 38.92%. The firm had revenue of $0.74 […] ....

United States , Jeff Cislini , Jack Anders , Raymond James , Metlife Investment Management , Revolution Medicines Inc , Dimensional Fund Advisors , Needham Company , Northern Trust Corp , Charles Schwab Investment Management Inc , Revolution Medicines Company Profile , Revolution Medicines , Get Free Report , General Counsel Jeff Cislini , Life Investment Management , Fund Advisors , Schwab Investment Management , Trust Corp , State Street Corp , Street Corp , Revolution Medicines Daily , Nasdaq Rvmd ,